Proposal for next phase expands eligibility for vaccines to nearly half the population. By Graham Kilmer - Jan 20th, 2021 03:49 pm //end headline wrapper ?>Get a daily rundown of the top stories on Urban Milwaukee
Dr. Ben Weston receives second dose of COVID-19 vaccine. File photo courtesy of the Medical College of Wisconsin.
If the latest draft of recommendations for the next phase of vaccinations is accepted by the state Department of Health Services, nearly half the state’s adult population will be eligible for the vaccine.
The state committee responsible for developing draft recommendations for the next phase of vaccinations met this morning and added new groups to a list that was released last week for public comment.
CDC / James Gathany
The Center for Infectious Disease Research and Policy (CIDRAP), with support from the Wellcome Trust, a London-based research nonprofit with an eye toward improving flu vaccines, promoting truly revolutionary versions, and ensuring more equitable distribution today released a draft of the Influenza Vaccines Research & Development Roadmap (IVR) for public review and comment.
The IVR project is being led by a steering group of scientists and policymakers and supported by a CIDRAP core team. It aims to develop a globally oriented influenza strategic planning tool to coordinate research and development (R&D), funding, and stakeholder engagement to produce more effective flu vaccines and reduce the impact of future influenza pandemics.
Governors say the federal government is holding back 50% of produced vaccine. //end headline wrapper ?>Get a daily rundown of the top stories on Urban Milwaukee
Freshly drawn up doses of the Pfizer-BioNTech COVID-19 vaccine are placed in a tray Thursday, Jan. 7, 2021, at SSM Health St. Mary’s Hospital – Madison. Angela Major/WPR
Eight state governors including Gov.
Tony Evers have written to the Trump administration asking the federal government to release more COVID-19 vaccine.
In a letter posted to Twitter Friday, the democratic governors said states need more doses of the vaccine now, a situation made more urgent because of a new variant of the virus.